Back
Immuneering Vs. ADMA Biologics Industry Stock Comparison
Buy
68
IMRX
Immuneering
Last Price:
1.69
Seasonality Move:
29.74%
Buy
72
ADMA
ADMA Biologics
Last Price:
10.78
Seasonality Move:
6.42%
Buy
68
Immuneering (IMRX)
is a Buy
Is Immuneering a Buy, Sell or Hold?
- The current Immuneering [IMRX] share price is $1.69. The Score for IMRX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- IMRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
- The current ADMA Biologics [ADMA] share price is $10.77. The Score for ADMA is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ADMA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IMRX Stock Price Chart
What is Immuneering's stock price today?
-
The Immuneering share price today is $1.69
The current trend is relatively stagnant and IMRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $10.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADMA is experiencing slight buying pressure.
IMRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 55.76 | Buy |
| Chaikin Money Flow: | 132706 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.38 - 1.58) | Buy |
| Bollinger Bands (100): | (1.27 - 5.57) | Sell |
ADMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 84.68 | Buy |
| Chaikin Money Flow: | 829639 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.82 - 10.44) | Buy |
| Bollinger Bands (100): | (5.14 - 8.58) | Buy |
IMRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.49 | Buy |
| 20-day SMA: | 1.47 | Buy |
| 50-day SMA: | 1.63 | Buy |
| 200-day SMA: | 5.19 | Sell |
| 8-day EMA: | 1.54 | Buy |
| 20-day EMA: | 1.52 | Buy |
| 50-day EMA: | 1.98 | Sell |
| 200-day EMA: | 4.66 | Sell |
ADMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.52 | Buy |
| 20-day SMA: | 9.89 | Buy |
| 50-day SMA: | 8.01 | Buy |
| 200-day SMA: | 5.36 | Buy |
| 8-day EMA: | 10.46 | Buy |
| 20-day EMA: | 9.8 | Buy |
| 50-day EMA: | 8.5 | Buy |
| 200-day EMA: | 6.03 | Buy |
Immuneering Earnings Growth & IMRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.16 per share, and an increase next year of $0.35 per share.
ADMA Biologics Earnings Growth & ADMA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.04 per share, an increase this year of $0.39 per share, and an increase next year of $0.20 per share.
Immuneering Technical Analysis
| May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ADMA Biologics Technical Analysis
| May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||